Tarsier Pharma Ltd.
Biotechnology / Ophthalmic biopharmaceuticals (ocular inflammatory diseases) · Zichron Yaacov, Israel
S-1 FiledTARX
Tarsier Pharma Ltd. IPO
Monitoring
S-1 Filed
Priced
Trading
Est. valuation
$35M
Exchange
—
Ticker: TARX
Status
S-1 Filed
Filed
Apr 21, 2026
IPO timeline
Apr 21, 2026
S-1 filed with SEC
Initial registration statement submitted to the Securities and Exchange Commission.
Upcoming
Roadshow & pricing
Company presents to institutional investors. IPO price and share count are finalized.
Upcoming
First-day trading
Shares available on the open market.
Frequently asked questions
When is Tarsier Pharma Ltd. going public?
Tarsier Pharma Ltd. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is Tarsier Pharma Ltd.'s IPO valuation?
The estimated offering value is $35M. Final valuation will be determined at pricing.
What exchange will Tarsier Pharma Ltd. list on?
No exchange has been officially announced for the Tarsier Pharma Ltd. IPO.
Has Tarsier Pharma Ltd. filed an S-1 with the SEC?
No. As of the most recent data, Tarsier Pharma Ltd. has not filed a Form S-1 or other registration statement with the SEC.
Sources: FireStrike proprietary index · SEC EDGAR